Daniel S. Hunter
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Polyomavirus and related diseases
- Immunology top 10%
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
Papers in
- Oncology 5
- CAR-T cell therapy research 4
- Cancer Immunotherapy and Biomarkers 1
-
- Immunotherapy and Immune Responses 3
- Immune cells in cancer 1
- Co-authors
- Kelly Garneski Paulson (1 shared paper)Teresa S. Kim (1 shared paper)William J. Valente (1 shared paper)Jean S. Campbell (1 shared paper)Jason H. Bielas (1 shared paper)Wei Hong Tan (1 shared paper)Kimberly S. Smythe (1 shared paper)Raphaël Gottardo (1 shared paper)
- Journals
- Nature Communications (2 papers)Blood (1 paper)The Journal of Immunology (1 paper)Nature Medicine (1 paper)Science Translational Medicine (1 paper)
- Partner nations
- United StatesBelgiumIceland
In The Last Decade
Daniel S. Hunter
6 papers receiving 537 citations
Peers
Comparison fields: 5 of 29
- Oncology 347
- Immunology 164
- Hematology 97
- Cancer Research 14
- Molecular Biology 59
Countries citing papers authored by Daniel S. Hunter
This map shows the geographic impact of Daniel S. Hunter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel S. Hunter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel S. Hunter more than expected).
Fields of papers citing papers by Daniel S. Hunter
This network shows the impact of papers produced by Daniel S. Hunter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel S. Hunter. The network helps show where Daniel S. Hunter may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel S. Hunter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 260 | |
| 2 | 2018 | 238 | |
| 3 | 2022 | 25 | |
| 4 | 2022 | 11 | |
| 5 | 2016 | 7 | |
| 6 | 2025 | 5 |
About Daniel S. Hunter
Daniel S. Hunter is a scholar working on Oncology, Immunology, Hematology, Nuclear Energy and Engineering and Waste Management and Disposal, having authored 6 papers that have together received 546 indexed citations. Recurring topics across this work include CAR-T cell therapy research (4 papers), Immunotherapy and Immune Responses (3 papers), Hematopoietic Stem Cell Transplantation (2 papers), Cancer Immunotherapy and Biomarkers (1 paper), Immune cells in cancer (1 paper) and Acute Myeloid Leukemia Research (1 paper). The work is most often cited by research in Oncology (347 citations), Immunology (164 citations), Hematology (97 citations), Cancer Research (14 citations) and Molecular Biology (59 citations). Daniel S. Hunter has collaborated with scholars based in United States, Belgium and Iceland. Frequent co-authors include Kelly Garneski Paulson, Teresa S. Kim, William J. Valente, Jean S. Campbell, Jason H. Bielas, Wei Hong Tan, Kimberly S. Smythe, Raphaël Gottardo, David R. Byrd and Robert Hamilton Pierce. Their work appears in journals such as Nature Communications, Blood, The Journal of Immunology, Nature Medicine and Science Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.